“…From these studies, it can be inferred that PDENs control inflammation from the transcriptional levels of mRNA, as some of these studies reported a lowered level of mRNA in various inflammatory markers. PDENs inhibit various intracellular signaling, such as AKT, GSK3β [ 190 ], TCF4, Nrf2 [ 200 ], NF-κB [ 185 ], and AhR [ 187 ], leading to altered transcriptional signaling and modulated downstream protein expressions. De Robertis et al (2020) and Yin et al (2022) reported hindered mRNA level of TNF-α, IL-1β, IL1R1, IL-6, IL-8, MAPK1, ICAM1, TLR8, HMOX1, and NFR1 after PDENs administration [ 195 , 202 ].…”